CTXR

Citius Pharmaceuticals, Inc.

0.66 USD
+0.01 (+1.74%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Citius Pharmaceuticals, Inc. stock is down -12.04% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 May’s closed higher than April.

About Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. engages in the development and commercialization of critical care products. The company is developing five proprietary products, including Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. MinoWrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, and Halo-Lido, a corticosteroid-lidocaine topical formulation.